Hyperuricemia—a serious complication among patients with chronic kidney disease: a systematic review and meta-analysis

Aim: Hyperuricemia as a putative risk factor for chronic kidney disease (CKD) progression remains controversial and debatable. This systematic review aims to explore the prevalence of hyperuricemia among CKD patients worldwide. Methods: This study was conducted in accordance with the Meta-analysi...

Full description

Bibliographic Details
Main Authors: Ishfaq Rashid, Pooja Katravath, Pramil Tiwari, Sanjay D’Cruz, Shivani Jaswal, Gautam Sahu
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2022-06-01
Series:Exploration of Medicine
Subjects:
Online Access:https://www.explorationpub.com/Journals/em/Article/100189
_version_ 1818244618280501248
author Ishfaq Rashid
Pooja Katravath
Pramil Tiwari
Sanjay D’Cruz
Shivani Jaswal
Gautam Sahu
author_facet Ishfaq Rashid
Pooja Katravath
Pramil Tiwari
Sanjay D’Cruz
Shivani Jaswal
Gautam Sahu
author_sort Ishfaq Rashid
collection DOAJ
description Aim: Hyperuricemia as a putative risk factor for chronic kidney disease (CKD) progression remains controversial and debatable. This systematic review aims to explore the prevalence of hyperuricemia among CKD patients worldwide. Methods: This study was conducted in accordance with the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines by using the existing literature from online databases such as MEDLINE/PubMed, ScienceDirect, Google Scholar, Cochrane library and grey literature. The effect size with corresponding 95% confidence interval (CI) was calculated to assess the pooled prevalence of hyperuricemia in chronic kidney patients. The subgroup analysis based on gender and geography was also carried out by utilizing comprehensive meta-analysis, version 2.0. Results: Twenty-three studies containing 212,740 participants were eligible for quantitative synthesis. The pooled prevalence of 43.6% (35.2–52.4%) hyperuricemia was reported in patients with CKD globally. In India, 38.4% of prevalence was observed. The gender specific prevalence (9 studies) was reported as 67.4% (60.9–73.3%) in case of male patients and 32.6% (26.7–39.1%) in female patients with 95% CI. Conclusions: The prevalence of hyperuricemia was reported to be reasonably high among CKD patients worldwide. During the management of CKD, this high prevalence demands more prudent attention for this clinical complication which possibly can lead to positive renal outcomes.
first_indexed 2024-12-12T14:19:53Z
format Article
id doaj.art-c066ed92df854e0080002e1834d81d66
institution Directory Open Access Journal
issn 2692-3106
language English
last_indexed 2024-12-12T14:19:53Z
publishDate 2022-06-01
publisher Open Exploration Publishing Inc.
record_format Article
series Exploration of Medicine
spelling doaj.art-c066ed92df854e0080002e1834d81d662022-12-22T00:21:49ZengOpen Exploration Publishing Inc.Exploration of Medicine2692-31062022-06-013324925910.37349/emed.2022.00089Hyperuricemia—a serious complication among patients with chronic kidney disease: a systematic review and meta-analysisIshfaq Rashid0https://orcid.org/0000-0001-8816-3987Pooja Katravath1Pramil Tiwari2https://orcid.org/0000-0003-0442-7880Sanjay D’Cruz3https://orcid.org/0000-0001-8831-8002Shivani Jaswal4Gautam Sahu5Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab 160062, IndiaDepartment of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab 160062, IndiaDepartment of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab 160062, IndiaDepartment of General Medicine, Government Medical College and Hospital, Chandigarh 160030, IndiaDepartment of Biochemistry, Government Medical College and Hospital, Chandigarh 160030, IndiaDepartment of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab 160062, IndiaAim: Hyperuricemia as a putative risk factor for chronic kidney disease (CKD) progression remains controversial and debatable. This systematic review aims to explore the prevalence of hyperuricemia among CKD patients worldwide. Methods: This study was conducted in accordance with the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines by using the existing literature from online databases such as MEDLINE/PubMed, ScienceDirect, Google Scholar, Cochrane library and grey literature. The effect size with corresponding 95% confidence interval (CI) was calculated to assess the pooled prevalence of hyperuricemia in chronic kidney patients. The subgroup analysis based on gender and geography was also carried out by utilizing comprehensive meta-analysis, version 2.0. Results: Twenty-three studies containing 212,740 participants were eligible for quantitative synthesis. The pooled prevalence of 43.6% (35.2–52.4%) hyperuricemia was reported in patients with CKD globally. In India, 38.4% of prevalence was observed. The gender specific prevalence (9 studies) was reported as 67.4% (60.9–73.3%) in case of male patients and 32.6% (26.7–39.1%) in female patients with 95% CI. Conclusions: The prevalence of hyperuricemia was reported to be reasonably high among CKD patients worldwide. During the management of CKD, this high prevalence demands more prudent attention for this clinical complication which possibly can lead to positive renal outcomes. https://www.explorationpub.com/Journals/em/Article/100189hyperuricemiachronic kidney diseaseprevalencegeographyuric acid
spellingShingle Ishfaq Rashid
Pooja Katravath
Pramil Tiwari
Sanjay D’Cruz
Shivani Jaswal
Gautam Sahu
Hyperuricemia—a serious complication among patients with chronic kidney disease: a systematic review and meta-analysis
Exploration of Medicine
hyperuricemia
chronic kidney disease
prevalence
geography
uric acid
title Hyperuricemia—a serious complication among patients with chronic kidney disease: a systematic review and meta-analysis
title_full Hyperuricemia—a serious complication among patients with chronic kidney disease: a systematic review and meta-analysis
title_fullStr Hyperuricemia—a serious complication among patients with chronic kidney disease: a systematic review and meta-analysis
title_full_unstemmed Hyperuricemia—a serious complication among patients with chronic kidney disease: a systematic review and meta-analysis
title_short Hyperuricemia—a serious complication among patients with chronic kidney disease: a systematic review and meta-analysis
title_sort hyperuricemia a serious complication among patients with chronic kidney disease a systematic review and meta analysis
topic hyperuricemia
chronic kidney disease
prevalence
geography
uric acid
url https://www.explorationpub.com/Journals/em/Article/100189
work_keys_str_mv AT ishfaqrashid hyperuricemiaaseriouscomplicationamongpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT poojakatravath hyperuricemiaaseriouscomplicationamongpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT pramiltiwari hyperuricemiaaseriouscomplicationamongpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT sanjaydcruz hyperuricemiaaseriouscomplicationamongpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT shivanijaswal hyperuricemiaaseriouscomplicationamongpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT gautamsahu hyperuricemiaaseriouscomplicationamongpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis